BiomX
Holding Companies & Conglomerates · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Einstein Fl 4, Ness Ziona, Al Awsaţ, ...Phone Number
+972723942377Website
www.biomx.comRevenue
-Stock Symbol
PHGEIndustry
ZI Rank: 6
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
2
7
4
4
6
About BiomX
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.Explore more
BiomX Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BiomX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BiomX had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if BiomX is spiking on competitors!
BiomX, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BiomX recently announced quarterly report
Funding: Get notified immidiatlly once BiomX has new funding data
Check if BiomX has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when BiomX launches new products
Congratulate Masked Content for being promoted to Masked Content at BiomX
Recommended Actions
Find VP level buyers at BiomX
Find 3 more new buyers
Company Profile Activity
Activity Insights
BiomX is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
BiomX is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about BiomX.
BiomX financials insights
Gather financial insights about BiomX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$24M
2019
Series B
$32M
2025
Other Financing Round
$12M
2026
Private Equity
$3.3M
BiomX Tech Stack
A closer look at the technologies used by BiomX
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
BiomX News & Media
BiomX Inc. (PHGE) Shareholder/Analyst Call Prepared Remarks Transcript
BiomX Inc. (PHGE) Shareholder/Analyst Call June 26, 2026 9:00 AM EDTCompany ParticipantsMichael Oster - CEO & DirectorPresentationMichael OsterCEO &...BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that its majority-owned subsidiary company DFSL Ltd. (“DFSL”) will showcase next-generation LADAR-based counter-drone and perimeter security solutions at ISC 2026.BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threatsBiomX Announces NYSE American Acceptance of Plan to Regain Compliance
NETANYA, Israel, June 12, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that the Company’s previously-submitted plan (the “Plan”) to regain compliance with NYSE American LLC’s listing standards was accepted, including plan compliance period through September 25, 2027.
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiomX
Sign Up For FreeTo access detailed company insights
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bact... Read More
